A Pilot study to evaluate paclitaxel (Taxol™) as primary medical treatment for patients with inoperable stage III and IV breast carcinoma
- 1 December 1996
- journal article
- clinical trial
- Published by Elsevier in European Journal Of Cancer
- Vol. 32 (13) , 2354-2356
- https://doi.org/10.1016/s0959-8049(96)00348-6
Abstract
No abstract availableKeywords
This publication has 6 references indexed in Scilit:
- Paclitaxel in Metastatic Breast Cancer:-a Trial of Two Doses by a 3-Hour Infusion in Patients With Dith Disease Recurrence After Prior Therapy With AnthracyclinesJNCI Journal of the National Cancer Institute, 1995
- Taxol1 (Paclitaxel) in Patients with Metastatic Breast Carcinoma Who Have Failed Prior Chemotherapy: Interim Results of a Multinational StudyOncology, 1994
- Paclitaxel and recombinant human granulocyte colony-stimulating factor as initial chemotherapy for metastatic breast cancer.Journal of Clinical Oncology, 1993
- Phase II Trial of Taxol, an Active Drug in the Treatment of Metastatic Breast CancerJNCI Journal of the National Cancer Institute, 1991
- Promotion of microtubule assembly in vitro by taxolNature, 1979
- Plant antitumor agents. VI. Isolation and structure of taxol, a novel antileukemic and antitumor agent from Taxus brevifoliaJournal of the American Chemical Society, 1971